PFM Health Sciences’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

PFM Health Sciences’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,613,516	Closed	-$10.8M	–	79
2023 Q3	$10.8M	Buy	1,613,516 +314,025	+24%	+$2.61M	0.51%	53
2023 Q2	$11.8M	Sell	1,299,491 -1,905,299	-59%	-$16.8M	0.46%	54
2023 Q1	$23.3M	Sell	3,204,790 -1,429,012	-31%	-$10.6M	1.03%	39
2022 Q4	$33.8M	Buy	4,633,802 +118,586	+3%	+$880K	1.21%	37
2022 Q3	$34.9M	Buy	+4,515,216	New	+$38.3M	1.26%	37

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

PFM Health Sciences's PNT Position: Q4 2023 in Review

PFM Health Sciences sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 1,613,516 shares — an estimated $10.8M sold.

PFM Health Sciences first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $34.9M in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

PFM Health Sciences reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
PFM Health Sciences sold 1,613,516 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $10.8M.
PFM Health Sciences first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
PFM Health Sciences's POINT Biopharma Global Inc. Common Stock position peaked at $34.9M in Q3 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on PFM Health Sciences's 13F filing for Q4 2023, filed 14 Feb 2024.